HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents
- PMID: 21339738
- DOI: 10.1038/onc.2011.21
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents
Abstract
DNA-damaging therapies represent a keystone in cancer treatment. Unfortunately, many tumors often relapse because of a group of cancer cells, which are resistant to conventional therapies. High-mobility group A (HMGA) proteins has a key role in cell transformation, and their overexpression is a common feature of human malignant neoplasias, representing a poor prognostic index often correlated to anti-cancer drug resistance. Our previous results demonstrated that HMGA1 is a substrate of ataxia-telangiectasia mutated (ATM), the main cellular sensor of genotoxic stress. Here we also report thatHMGA2, the other member of the HMGA family, is a novel substrate of ATM. Interestingly, we found that HMGA proteins positively regulate ATM gene expression. Moreover, induction of ATM kinase activity by DNA-damaging agents enhances HMGA-dependent transcriptional activation of ATM promoter, suggesting that ATM expression is modulated by a DNA-damage- and HMGA-dependent positive feedback loop. Finally, inhibition of HMGA expression in mouse embryonic fibroblasts and in cancer cells strongly reduces ATM protein levels, impairing the cellular DNA-damage response and enhancing the sensitivity to DNA-damaging agents. These findings indicate this novel HMGA-ATM pathway as a new potential target to improve the effectiveness of conventional anti-neoplastic treatments on the genotoxic-drug resistant cancer cells.
Similar articles
-
HMGA1 protein is a novel target of the ATM kinase.Eur J Cancer. 2008 Nov;44(17):2668-79. doi: 10.1016/j.ejca.2008.07.033. Epub 2008 Sep 8. Eur J Cancer. 2008. PMID: 18783938
-
Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway.Oncogene. 2002 Nov 7;21(51):7776-85. doi: 10.1038/sj.onc.1205981. Oncogene. 2002. PMID: 12420214
-
Role for ATM in DNA damage-induced phosphorylation of BRCA1.Cancer Res. 2000 Jun 15;60(12):3299-304. Cancer Res. 2000. PMID: 10866324
-
The ATM-dependent DNA damage signaling pathway.Cold Spring Harb Symp Quant Biol. 2005;70:99-109. doi: 10.1101/sqb.2005.70.002. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869743 Review.
-
[Ataxia-telangiectasia mutated gene and breast cancer susceptibility].Sheng Wu Gong Cheng Xue Bao. 2010 Jan;26(1):9-15. Sheng Wu Gong Cheng Xue Bao. 2010. PMID: 20353086 Review. Chinese.
Cited by
-
Polypyrimidine tract-binding protein 3/insulin-like growth factor 2 mRNA-binding proteins 3/high-mobility group A1 axis promotes renal cancer growth and metastasis.iScience. 2024 Feb 9;27(3):109158. doi: 10.1016/j.isci.2024.109158. eCollection 2024 Mar 15. iScience. 2024. PMID: 38405614 Free PMC article.
-
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma.Cell Cycle. 2023 Dec-Dec;22(23-24):2552-2565. doi: 10.1080/15384101.2023.2298027. Epub 2024 Jan 2. Cell Cycle. 2023. PMID: 38165007
-
Aberrant HMGA2 Expression Sustains Genome Instability That Promotes Metastasis and Therapeutic Resistance in Colorectal Cancer.Cancers (Basel). 2023 Mar 13;15(6):1735. doi: 10.3390/cancers15061735. Cancers (Basel). 2023. PMID: 36980621 Free PMC article. Review.
-
Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling.Int J Mol Sci. 2023 Feb 20;24(4):4246. doi: 10.3390/ijms24044246. Int J Mol Sci. 2023. PMID: 36835656 Free PMC article.
-
Multi-layered chromatin proteomics identifies cell vulnerabilities in DNA repair.Nucleic Acids Res. 2023 Jan 25;51(2):687-711. doi: 10.1093/nar/gkac1264. Nucleic Acids Res. 2023. PMID: 36629267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous